The overall OR from nine studies, including 582 male and 417 female patients with CRC, demonstrated that CD166 expression was not correlated with gender (OR = 0.89, 95% CI = 0.68-1.17, P = 0.414). The gene discussed is ALCAM; the disease is colorectal carcinoma.